Management of immediate partial bioresorbable vascular scaffold stent thrombosis [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(2): 167-171 | DOI: 10.5543/tkda.2016.21866

Management of immediate partial bioresorbable vascular scaffold stent thrombosis

Ziad Said Dahdouh1, Bahaa M Fadel1, Hani Al Sergani1, Jehad Al Buraiki1, Gilles Grollier2
1Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2Department of Interventional Cardiology, University Hospital of Caen, Caen, France

Bioresorbable vascular scaffold (BVS) stents have been proposed recently as an elegant technique for treatment of coronary artery disease. However, perspective that these “dissolvable” stents will replace conventional metallic stents in broad spectrum of clinical conditions and patient categories in the near future has been moderated by non-negligible incidence of stent thrombosis (ST). Mechanical factors, such as strut thickness and malapposition have been implicated in increased risk of BVS ST. Presently described is case of immediate partial BVS ST in a young male related to technical procedural problem, rather than mechanical problem. Glycoprotein IIb/IIIa inhibitors associated with anticoagulation resulted in complete resolution of thrombus and facilitated successful patient outcome.

Keywords: Bioresorbable vascular scaffold, glycoprotein IIb/IIIa inhibitors, in-scaffold thrombosis, percutaneous coronary intervention.

How to cite this article
Ziad Said Dahdouh, Bahaa M Fadel, Hani Al Sergani, Jehad Al Buraiki, Gilles Grollier. Management of immediate partial bioresorbable vascular scaffold stent thrombosis. Turk Kardiyol Dern Ars. 2017; 45(2): 167-171

Corresponding Author: Ziad Said Dahdouh, Saudi Arabia
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale